Rheinmetall

Rheinmetall in 2026 is no longer a cyclical industrial — it is the strategically most important land-warfare prime in Europe, with NATO-level relevance. As of Q1/2026 the order book stands at roughly €88B, which against a 2026 revenue target of €16B implies a book-to-bill above 5×. That visibility is unmatched in the European industrial sector.

The structural change is the EU Rearm program: the €800B capacity facility and SAFE bonds approved in autumn 2025 are now sending real cash to European defense ministries, and a disproportionate share flows to Rheinmetall — simply because it is the only operator with immediately scalable 155mm ammunition lines inside the EU. The Unterlüß and Várpalota (Hungary) plants are running at 700,000 rounds per year in Q1/2026, with capacity expansion to 1.1M rounds penciled in for end-2027.

The margin lever is the mix shift away from classic ammunition (15–17% EBIT margin) toward complex systems like the Panther KF51, Lynx IFV, and Skyranger air-defense (22–28% EBIT margin). Q1/2026 group EBIT margin came in at 13.6%; management is guiding toward 15%+ in 2027 on materially higher revenue. That is the basis for sell-side EPS doubling between 2025 and 2028.

The Q1/2026 13F filings (US visibility via NYSE ADRs) show steady institutional accumulation: BlackRock up to 6.2% from 5.1%, Norges Bank up to 3.4% (doubled in 12 months), Capital Group a new 1.9% stake. Highly unusual for a German mid-cap.

On the activist side, Trian Partners (Nelson Peltz) has publicly campaigned for a US listing, arguing that Rheinmetall trades at a structural Frankfurt-multiple discount — a secondary NYSE listing or a civilian-business spin-off could deliver 20%+ multiple expansion. On the bear side, Citron Research published an early-2026 short report arguing that EBIT margin will roll over by 2028 once ammunition allocation normalizes — the market largely ignored it.

Rheinmetall trades at 27× 2026 P/E and 19× 2027 consensus earnings, EV/EBITDA of 14× FY+1. In the defense peer set this sits between Lockheed Martin (16× P/E, 11× EBITDA) and BAE Systems (24× P/E, 14× EBITDA). A DCF using 9% WACC and €3.8B of 2028 EBIT (consensus) produces a fair-value range of €580–740. Current price on 15-May-2026 is around €640 — roughly fair on consensus assumptions, with upside optionality on margin expansion.

1. September 2026: Bundeswehr framework contract 2 for the main 155mm ammunition tranche — expected volume €3.2B over seven years. The award is essentially Rheinmetall's, but the market is waiting on the implied price point.
2. November 2026: Capital Markets Day with updated 2028 outlook — the market expects a revenue-target lift from €30B to €38–40B and an EBIT margin guide of 16%+.
3. Q1 2027: First Panther KF51 delivery to Hungary — politically sensitive handover that could open the door to Leopard 2 comparisons and follow-on orders from Scandinavia.

Rheinmetall is the only European industrial with a structural, geopolitically anchored tailwind that will outlast multiple cycles. But valuation and sentiment are hot — investors who entered below €200 in 2022 made 3×; the margin of safety for new entrants is limited. I hold a 3% portfolio weight via a 12-month savings plan ramping to 5%. I only add aggressively after a real correction (-25%+) or on a hard turn in the Ukraine conflict.